Skip to main content

Table 1 Selected studies exploring quality of life and frailty in AKI survivors

From: Survive or thrive after ICU: what’s the score?

Study

Location

Years of enrolment

Design

AKI population

QOL or Frailty questionnaire Response rate / total population

Instrument

Assessment time point

Comments/Main findings

Soliman et al. [7]

Netherlands

July 2009 until April 2013

Single center retrospective analysis

Patients with early RIFLE AKI in ICU and alive at 1 year

1020 / 1549 (65.8%)

EuroQoL 5D-3L™ (EQ-5D)

1 year

All AKI categories were associated with a primary outcome of EQ-5L < 0.4 or death but at 1 year, AKI category was not associated with HRQOL

Salathe et al. [9]

Switzerland

January 2015 until April 2018

Single site observational study

All patients > 55 who received RRT for AKI and were alive in May 2019

83/119 (69.7%)

EQ-5D with VAS

 

VAS score was 71 (SD 22) and mean EQ-5D derived health utility 0.76 (IQR 0.26). Pain was the most frequently reported limitation (46.9%), followed by mobility (36.1%) and anxiety (21.6%); Scores were significantly lower in patients older than 75 years compared to younger patients; QOL was significantly lower than an age/sex matched reference population

Thanapongsatorn et al. [10]

Thailand

August 2018 to January 2021

Randomised controlled trial

Severe AKI stage 2–3 and alive at 12 months

78/98 (79%)

EQ-5D-5L

1 year

No statistically significant difference in EQ-5D-5L index

scores between the comprehensive care and control group (0.99 [0.8–1.0] vs 0.96 [0.8–1.0], p = 0.80)

Mishra et al. [11]

United Kingdom

January 2005 until

December 2011

Observational cohort study

Patients with RIFLE –I or higher AKI post cardiac surgery and alive at least 1 year post surgery

499/777 (64%)

SF-12 v2)

At least 1 year

Median follow-up for patients who returned the QOL

questionnaires were 60 months (30, 113) for the AKI group and 63 months (30, 112) for non-AKI patients. Mental scores were not significantly different (51.0 [18.5, 70.8] vs. 52.2 [21.8, 70.6], P = 0.2) between both groups but the physical scores were (38.8 [14.2, 62.5] vs. 44.2 [13.8, 76.7], P< 0.01)

Studies examining clinical frailty score post AKI

Beaubien-Souligny et al. [5]

Canada

September 2013 until November 2015

Multicentre prospective cohort study at 6 and 12 months

ICU patients ≥ 65 years with severe AKI and alive at 90 days

243 / 499 at 6 months (87%)

216 / 499 at 12 months (81%)

CFS

At baseline,90 days and 6 months

Frailty was independently

associated with 90-day mortality (adjusted HR

1.49; 95% CI 1.11–2.01, p = 0.008); 243 (53%) patients were alive and had CFS scores captured. Among these, 68 (28%) were frail including 39 (57%) patients who were not frail at baseline

Abdel-Kader et al. [6]

USA

2007 to 2010

Prospective cohort study in 5 US medical centers

Critically ill adults with acute respiratory failure and/or septic or cardiogenic shock and KDGIO-AKI

317/371 at 3 months (85%)

318/371 at 12 months (86%)

CFS

Baseline 3 and 12 months

Peak AKI was generally associated with higher CFS scores at 12 months (AKI stage 1: OR 1.87, 95% CI 1.11, 3.14; AKI stage 2: OR 1.81, 95% CI 0.94, 3.48; AKI stage 3: OR 2.76, 95% CI 1.34, 5.66)

  1. AKI acute kidney injury, HR hazard ratio, RIFLE Risk–Injury–Failure–Loss–End-stage, RRT renal replacement therapy, VAS visual analog scale, IQR interquartile range, CFS clinical frailty score, QOL quality of life, KDIGO Kidney Disease Improving Global Outcomes, OR odds ratio, CI Confidence interval